Skip to main content
. 2021 Jul 9;13(7):1053. doi: 10.3390/pharmaceutics13071053

Figure 4.

Figure 4

Schematic representation of the inability of drug molecules and proteins to penetrate the BBB in the absence of FUS (A). Focused ultrasound-mediated microbubble cavitation facilitates the disruption of the BBB, allowing for enhanced delivery of therapeutic molecules (B).